![]() | Up a level |
Number of items: 1.
Gebrehiwet, Paulos, Meng, Lisa, Rudnicki, Stacy A, Sarocco, Phil, Wei, Jenny, Wolff, Andrew A, Butzner, Michael, Chiò, Adriano, Andrews, Jinsy A, Genge, Angela et al (show 5 more authors)
(2023)
Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving <i>reldesemtiv</i> or placebo in FORTITUDE-ALS.
Journal of medical economics, 26 (1).
pp. 488-493.